2022-02-22

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?

In this op-ed, Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, board-certified obstetrician and gynecologist, former chief medical research advisor for the American Society for Colposcopy and Cervical Pathology, and former professor at Duke University Medical Center and at Vanderbilt University Medical Center, shares his vision.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31
Cervical Cancer | Webinars & Videos
ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31
BD Onclarity HPV Assay
Cervical Cancer | News & Updates
Press Release: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease
Cervical Cancer | News & Updates
Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease